Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

NCT01369095 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

976

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

DRUG: Duloxetine
DRUG: Escitalopram
DRUG: BMS-820836 Placebo
DRUG: BMS-820836
DRUG: BMS-820836
DRUG: BMS-820836
DRUG: BMS-820836

Sponsor

Bristol-Myers Squibb